drugset
drugset / Trial / NCT05089279

Study to Evaluate the Safety and Pharmacokinetics of CKD-349 in Healthy Adult Volunteers

NCT05089279 ↗

Phase 1 Completed 71 enrolled Chong Kun Dang Pharmaceutical
RandomizedCrossoverOpen-labelTreatment

Summary

Study to Evaluate the Safety and Pharmacokinetics of CKD-349

Timeline

Start
2021-11-03
Primary completion
2022-01-18
Completion
2022-04-06

Drugs

EvaluationDrugModalityDoseRoute
Subject CKD-349 Unknown — Oral
Subject D113 Unknown — Oral

Indications

heart failure